点击显示 收起
| 063 | Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of Procalcitonin for differentiation between activity of systemic autoimmune disease and invasive bacterial infection Arthritis and Rheumatism 1997; 40 (7): 1250-1256 |
| 209 | Stroehmann A, Cowell LG, Hiepe F, Krause A. Zum Stellenwert von Procalcitonin in der rheumatologischen Diagnostik Med. Klinik 1998; 93: P-185 Abstract-Band1 |
| 244 | Mosig F, Csernod E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's granulomatosis J. Rheumatol. 1998, 25(8): 1531-1533 |
| 245 | Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be pecifled by measurement of procalcitonin Infection 1998, 26: 274-276 |
| 302 | Moosig F, Reinhold-Keller E, Csernok E, Gross WL. Limitations on the usefuiness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: omment on the article by Eberhard et al [letter; comment] Arthritis Rheum 1998, 41(3): 566-567 |
| 303 | Espinosa-Morales R, Escalant, A. Use of procalcitonin as a diagnostic test: Comment on the article by Eberhard et al [letter; comment] Arthritis Rheum 1998, 41(3): 567-568 |
| 371 | Brunkhorst R, Eberhard OK, Hauvitz M, Brunkhorst FM Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection Intensive Care Med. 2000, 26(Suppl 2): S199-201 |
| 385 | Ruchardt A, Lydtin H. Morbus Still des Euwachsenen DMW 1999, 124(50): 1541 |
| 429 | Andrassy K, Hansch G. Vasculitis 1998: New insights into diagnosis and therapy [in German] WMW 2000, 11: 230-232 |